Replacement Half Year Report

The tables in the "Half-year Report" announcement released on 30 September 2025 at 7am under RNS No 3030B were unclear and accordingly the announcement has been updated so that readers can access the tables via a pdf link now contained in the announcement.

All other details remain unchanged.

The full amended text is shown below.

Ovoca Bio PLC

Ovoca Bio plc

("Ovoca" or the "Company")

Interim Results for the six months ended 30 June 2025

Dublin, Ireland, 30 September 2025 - Ovoca Bio announces its interim financial statements and report covering the six-months ending 30 June 2025.

Please click on the following link to view the full Half Year Report and extracts are set out at the end of this announcement:

CEO Statement

Today we have published Ovoca's financial statements covering the six-month period to the end of June 2025, which I encourage all stakeholders to read. On 7 May 2025 the Company entered into a conditional Letter of Intent ("LOI") to acquire 100% of Tadeen International Limited ("Tadeen"), a UK-registered company, which indirectly owns 100% of a portfolio of mineral exploration licenses in Morocco prospective for Copper and Silver (the "Proposed Acquisition"). The team at Ovoca has been working to complete the Proposed Acquisition and in due course further announcements will be made as we finalize the acquisition of Tadeen.

As at 30 June 2025, the Company had cash and cash equivalents amounting to €1,526 million ($ 1,788 million) and we will continue to carefully manage our financial resources. The costs incurred during the period relate to the costs of work in relation to the Proposed Acquisition along with corporate costs.

I would like to thank the management team of the Company and the Board of Directors for their support.